Skip to content

Drug interactions

Ethinyl estradiol-drospirenone + Sparsentan

Severity: Major

Ethinyl estradiol-drospirenone and Sparsentan: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sparsentan can cause hyperkalemia through its effects on the renin-angiotensin system, and drospirenone adds anti-mineralocorticoid potassium retention. The combination raises hyperkalemia risk, especially in kidney disease. Sparsentan is also teratogenic and requires reliable contraception.

What this interaction means in plain words

Ethinyl estradiol-drospirenone and Sparsentan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Ethinyl estradiol-drospirenone belongs to Endocrine; Sparsentan belongs to Genitourinary.

Evidence level: Moderate

Why it happens

Additive potassium retention from angiotensin receptor blockade and aldosterone receptor antagonism.

What to do

Monitor serum potassium frequently, especially at the start. Consider a contraceptive without drospirenone if potassium rises.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ethinyl estradiol-drospirenone and Sparsentan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ethinyl estradiol-drospirenone with Sparsentan?

MediHelp rates the interaction as major. Ethinyl estradiol-drospirenone and Sparsentan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Sparsentan can cause hyperkalemia through its effects on the renin-angiotensin system, and drospirenone adds anti-mineralocorticoid potassium retention. The combination raises hyperkalemia risk, especially in kidney disease. Sparsentan is also teratogenic and requires reliable contraception.

How serious is the interaction between Ethinyl estradiol-drospirenone and Sparsentan?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium frequently, especially at the start. Consider a contraceptive without drospirenone if potassium rises.

What other medicines interact with Ethinyl estradiol-drospirenone?

MediHelp also lists interactions of Ethinyl estradiol-drospirenone with, for example, Fezolinetant, Ombitasvir / paritaprevir / ritonavir, Ombitasvir / paritaprevir / ritonavir and dasabuvir. The full list is on the Ethinyl estradiol-drospirenone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in